Liver Diseases  >>  combretastatin A1 di-phosphate (OXi4503)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
combretastatin A1 di-phosphate (OXi4503) / Oncotelic
OXi4503, NCT00960557: Safety Study of Increasing Doses of Combretasatin A1 Diphosphate () as Monotherapy in Subjects With Hepatic Tumor Burden

Completed
1b/2
16
RoW
Combretastatin A1 Diphosphate (OXi4503)
Mateon Therapeutics
Neoplasm Metastasis
10/10
10/10

Download Options